Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate vs. Delayed Postpartum LNG-IUS (PPIUD1)
NCT01555931Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Mar 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of avatrombopag in contraception (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Breastfeeding Prevalence at 6 months. Started Mar 2012; status: completed.
02
Drugs
avatrombopag
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01555931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01555931.